BNP Paribas Financial Markets’s Boundless Bio BOLD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$196 Buy
178
+2
+1% +$2 ﹤0.01% 5630
2025
Q4
$211 Sell
176
-173
-50% -$216 ﹤0.01% 5564
2025
Q3
$429 Sell
349
-1,621
-82% -$1.87K ﹤0.01% 5325
2025
Q2
$1.99K Sell
1,970
-16,923
-90% -$22.5K ﹤0.01% 5058
2025
Q1
$28.5K Sell
18,893
-885
-4% -$1.83K ﹤0.01% 4443
2024
Q4
$57.4K Buy
19,778
+282
+1% +$822 ﹤0.01% 4377
2024
Q3
$67.7K Buy
19,496
+18,996
+3,799% +$68.8K ﹤0.01% 3554
2024
Q2
$1.94K Buy
+500
New +$4.78K ﹤0.01% 3815

Other funds holding BOLD

BNP Paribas Financial Markets's BOLD Position: Q1 2026 in Review

BNP Paribas Financial Markets increased its Boundless Bio (BOLD) stake by 1.1% in Q1 2026, buying an estimated $2 and bringing the position to 178 shares worth $196. The position accounts for ﹤0.01% of the portfolio, ranked #5630.

BNP Paribas Financial Markets first reported a position in BOLD in Q2 2024 and has held it in 8 quarters since. The position peaked at $67.7K in Q3 2024. 36 funds tracked by Wall St. Rank hold BOLD as of Q1 2026.

  • BNP Paribas Financial Markets held 178 shares of Boundless Bio worth $196 as of Q1 2026.
  • BNP Paribas Financial Markets bought 2 Boundless Bio shares in Q1 2026, an estimated $2.
  • Boundless Bio made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q1 2026, its #5630 holding.
  • BNP Paribas Financial Markets first reported a position in Boundless Bio in Q2 2024 and has held it in 8 quarters since.
  • BNP Paribas Financial Markets's Boundless Bio position peaked at $67.7K in Q3 2024.
  • 36 funds tracked by Wall St. Rank held Boundless Bio as of Q1 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2026, filed 12 May 2026.